KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Shares Outstanding (Weighted Average) (2016 - 2026)

Medtronic's Shares Outstanding (Weighted Average) history spans 13 years, with the latest figure at $1.3 billion for Q1 2026.

  • For Q1 2026, Shares Outstanding (Weighted Average) changed 0.32% year-over-year to $1.3 billion; the TTM value through Jan 2026 reached $1.3 billion, changed 0.32%, while the annual FY2025 figure was $1.3 billion, 3.17% down from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 was $1.3 billion at Medtronic, roughly flat from $1.3 billion in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $1.3 billion in Q1 2022 and bottomed at $1.3 billion in Q3 2025.
  • The 5-year median for Shares Outstanding (Weighted Average) is $1.3 billion (2022), against an average of $1.3 billion.
  • The largest annual shift saw Shares Outstanding (Weighted Average) increased 0.08% in 2023 before it decreased 3.23% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $1.3 billion in 2022, then increased by 0.06% to $1.3 billion in 2023, then fell by 3.13% to $1.3 billion in 2024, then fell by 0.51% to $1.3 billion in 2025, then rose by 0.05% to $1.3 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Shares Outstanding (Weighted Average) are $1.3 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025).